Skip to main content

Advertisement

Log in

Importance of the development time of isolated bone metastasis in breast cancer

  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background and aims

To investigate whether isolated bone metastases at the time of diagnosis is a different entity than bone metastases after breast cancer surgery.

Patients and methods

One hundred thirty-nine patients were examined between June 2004 and January 2007. These patients were classified into synchronous (group I) and metachronous groups (group II) depending on time to development of bone metastases. Patients and tumor characteristics, treatment, clinical progression, and survival were compared for each group.

Results

There were 44 patients in group I and 95 patients in group II. The median follow-up time was 36 months. The two groups showed similar results when patients, tumor characteristics, and clinical progression were compared. In the groups, the median time to progression was 14 vs 13 months (p = 0.70), and median overall survival was 47 vs 46 months (p = 0.96), respectively.

Conclusion

Development time of bone metastasis has no effect on clinical progression, time to progression, and overall survival in breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Coleman RE, Smith P, Rubens RD (1998) Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer 77(2):336–340

    Article  PubMed  CAS  Google Scholar 

  2. Galasko CSB (1981) The anatomy and pathways of skeletal metastases. Bone metastases. Hall Medical Publishers, Boston, pp 49–63

    Google Scholar 

  3. Khan SA, Stewart AK, Morrow M (2002) Does aggressive local therapy improves survival in metastatic breast cancer? Surgery 132(4):620–626

    Article  PubMed  Google Scholar 

  4. Babiera GV, Rao R, Feng L et al (2006) Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 13(6):776–778

    Article  PubMed  Google Scholar 

  5. Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM (2008) Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg 247(5):732–738

    Article  PubMed  Google Scholar 

  6. Rapiti E, Verkooijen HM, Vlastos G et al (2006) Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 24(18):2743–2749

    Article  PubMed  Google Scholar 

  7. Jacobson AF, Shapiro CL, Van den Abbeele AD, Kaplan WD (2001) Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma. Cancer 91(1):17–24

    Article  PubMed  CAS  Google Scholar 

  8. Briasoulis E, Karavasilis V, Kostadima L, Ignatiadis M, Fountzilas G, Pavlidis N (2004) Metastatic breast carcinoma confined to bone: portrait of a clinical entity. Cancer 101(7):1524–1528

    Article  PubMed  Google Scholar 

  9. Esteva FJ, Valero V, Pusztai L, Boehnke-Michaud L, Buzdar AU, Hortobagyi GN (2001) Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. Oncologist 6(2):133–146

    Article  PubMed  CAS  Google Scholar 

  10. Carmichael AR, Anderson ED, Chetty U, Dixon JM (2003) Does local surgery have a role in the management of stage IV breast cancer? Eur J Surg Oncol 29(1):17–19

    Article  PubMed  CAS  Google Scholar 

  11. Gnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C, Margenthaler JA (2007) Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988–2003 SEER data. Ann Surg Oncol 14(8):2187–2194

    Article  PubMed  Google Scholar 

  12. Grene FL, Page DL, Fleming ID et al (2002) AJCC cancer staging manual 6th ed. Springer-Verlag, New York

    Google Scholar 

  13. Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN (2004) Is breast cancer survival improving? Cancer 100(1):44–52

    Article  PubMed  Google Scholar 

  14. Andre F, Slimane K, Bachelot T et al (2004) Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol 22(16):3302–3308

    Article  PubMed  Google Scholar 

  15. Sherry MM, Greco FA, Johnson DH, Hainsworth JD (1986) Metastatic breast cancer confined to the skeletal system. An indolent disease. Am J Med 81(3):381–386

    Article  PubMed  CAS  Google Scholar 

  16. Dauplat J, Le Bouëdec G, Pomel C, Scherer C (2000) Cytoreductive surgery for advanced stages of ovarian cancer. Semin Surg Oncol 19(1):42–48

    Article  PubMed  CAS  Google Scholar 

  17. Goldie JH, Coldman AJ (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63(11–12):1727–1733

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

I thank Murat Ulvi Yüksel for his editorial assistance.

Conflict of interest statement

No conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sevim Turanli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Turanli, S. Importance of the development time of isolated bone metastasis in breast cancer. Langenbecks Arch Surg 397, 967–972 (2012). https://doi.org/10.1007/s00423-009-0561-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-009-0561-1

Keywords

Navigation